Literature DB >> 12393419

Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production.

Hélène Gary-Gouy1, Julie Harriague, Georges Bismuth, Cornelia Platzer, Christian Schmitt, Ali H Dalloul.   

Abstract

CD5 is a negative regulator of B-cell receptor (BCR) signaling that is up-regulated after BCR stimulation and likely contributes to B-cell tolerance in vivo. However, CD5 is constitutively expressed on the B-1 subset of B cells. Contrary to CD5(-) B-2 B cells, B-1 B cells are long-lived because of autocrine interleukin-10 (IL-10) production through unknown mechanisms. We demonstrate herein a direct relationship between CD5 expression and IL-10 production. Human peripheral blood CD5(+) B cells produce more IL-10 than CD5(-) B cells after BCR activation. Introducing CD5 into CD5(-) B cells induces the production of IL-10 by activating its promoter and the synthesis of its mRNA. The cytoplasmic domain of CD5 is sufficient for this process. CD5 also protects normal human B cells from apoptosis after BCR stimulation while reducing the BCR-induced Ca(2+) response. We conclude that CD5 supports the survival of B cells by stimulating IL-10 production and by concurrently exerting negative feedback on BCR-induced signaling events that can promote cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393419     DOI: 10.1182/blood-2002-05-1525

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  73 in total

1.  Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.

Authors:  Fanli Hua; Lili Ji; Yanxia Zhan; Feng Li; Shanhua Zou; Xiaoyun Wang; Dongli Song; Zhihui Min; Song Gao; Yangjiong Wu; Hao Chen; Yunfeng Cheng
Journal:  J Clin Immunol       Date:  2012-06-06       Impact factor: 8.317

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

3.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

Review 4.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

5.  Btk regulates multiple stages in the development and survival of B-1 cells.

Authors:  Cristina M Contreras; Kristina E Halcomb; Lindsey Randle; Rochelle M Hinman; Toni Gutierrez; Stephen H Clarke; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2007-01-04       Impact factor: 4.407

6.  Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways.

Authors:  Hernán F Peñaloza; Loreani P Noguera; Danielle Ahn; Omar P Vallejos; Raquel M Castellanos; Yaneisi Vazquez; Francisco J Salazar-Echegarai; Liliana González; Isidora Suazo; Catalina Pardo-Roa; Geraldyne A Salazar; Alice Prince; Susan M Bueno
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

7.  CD5 sweetens lymphocyte responses.

Authors:  Laurel L Lenz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

8.  Splenectomy prior to allogeneic hematopoietic SCT increases the risk of post-transplant lymphoproliferative disease.

Authors:  M Uhlin; M M Norström; J Mattsson; M Remberger
Journal:  Bone Marrow Transplant       Date:  2013-12-16       Impact factor: 5.483

Review 9.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

10.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.